Skip to main content


Brigham president had sold more Moderna stock before she resigned from biotech's board

By The Boston Globe  
   August 05, 2020

The head of Brigham and Women's Hospital sold nearly $2 million worth of Moderna stock in May, just as the institution she led was preparing cost-cutting due to COVID-19, bringing her total earnings from the biotech company to $8.5 million this year.

Full story

Get the latest on healthcare leadership in your inbox.